Healthcare, pharmaceuticals and life sciences operate in a highly regulated environment where product safety, scientific evidence, public interest, pricing pressure and reputational risk often meet. The firm supports healthcare institutions, pharmaceutical companies, medical-device businesses, clinical research organisations and life-sciences clients on Greek-law regulatory, commercial and contentious matters.

Our work covers medicinal products, medical devices, cosmetics, product classification, labelling and packaging, advertising and promotion, product safety, distribution, clinical trials, human tissues and cells, commercial agreements, IP, data protection, competition, employment and dispute strategy. Clients in the sector have included leading international hospitals and healthcare institutions such as The Royal Marsden Hospital, The London Clinic, Mayo Clinic and Cleveland Clinic, as well as pharmaceutical and life-sciences companies including Pfizer, AstraZeneca, Gilead Sciences and Elan Pharmaceuticals.

The practice has particular experience in healthcare-related disputes, medical negligence matters and product-related claims, where legal strategy must account for regulatory exposure, expert evidence, confidentiality, reputation and patient sensitivity. We also support clients on the commercial and operational arrangements behind healthcare and life-sciences activity in Greece, including distribution, research, data use, employment and regulatory compliance.

Sector matters are handled through a coordinated team drawing on regulatory, commercial, data protection, IP, public law, employment and disputes experience, allowing clients to manage both day-to-day Greek operations and higher-risk matters involving regulators, counterparties, patients or public scrutiny.